Madame Bioscience Public Company Limited

Total Valuation

Madame Bioscience Public Company Limited carries a market capitalization of 1.65B, placing it among publicly traded companies globally. Its enterprise value stands at 974.79M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Madame Bioscience Public Company Limited currently has 3.43B shares outstanding.

Valuation Ratios

The price-to-sales ratio is 0.30, and the price-to-book ratio stands at 0.64.

Enterprise Valuation

On an enterprise value basis, Madame Bioscience Public Company Limited trades at an EV/EBITDA multiple of 4.85 and an EV/FCF ratio of 6.58. The EV/Sales ratio of 0.56 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 21.34 provides insight into valuation relative to core operating earnings.

Financial Position

Madame Bioscience Public Company Limited maintains a current ratio of 0.92, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 56.28, indicating elevated leverage, while an interest coverage ratio of -0.68 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Taxes

Over the trailing twelve months, Madame Bioscience Public Company Limited has paid 3.77M in income taxes, reflecting an effective tax rate of 13.73.

Stock Price Statistics

Madame Bioscience Public Company Limited's stock has gained approximately 166.66667% over the past 52 weeks. The 50-day moving average sits at 0.18, while the 200-day moving average is 0.17.

Income Statement

Over the trailing twelve months, Madame Bioscience Public Company Limited generated 1.75B in revenue and converted that into -86.18M in net income, yielding earnings per share of -0.03. EBITDA reached -28.90M, while operating income came in at -105.43M.

Balance Sheet

Madame Bioscience Public Company Limited holds 42.02M in cash and equivalents against 442.93M in total debt, resulting in a net debt position of 235.49M. Total book value stands at 824.98M, with working capital of -39.33M providing operational flexibility.

Cash Flow

Madame Bioscience Public Company Limited produced 91.99M in operating cash flow over the past twelve months. After subtracting -11.57M in capital expenditures, free cash flow totaled 80.42M - equivalent to 0.02 per share.

Margins

Madame Bioscience Public Company Limited operates with a gross margin of 16.85, reflecting its pricing power and cost economics. The operating margin of -6.01 and net profit margin of -4.91 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

Madame Bioscience Public Company Limited's most recent stock split took place on December 2, 2022 with a 2:1 split ratio.

Scores

Madame Bioscience Public Company Limited posts an Altman Z-Score of 0.52, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.